| Jennifer Ann Alderink, DO | |
|
900 I St, La Porte, IN 46350-5533 | |
| (219) 324-1700 | |
| (219) 324-1602 |
| Full Name | Jennifer Ann Alderink |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 900 I St, La Porte, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164651758 | NPI | - | NPPES |
| 201008190 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 02003760A (Indiana) | Primary |
| 207Q00000X | Family Medicine | 5101019506 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Laporte Home Health | La porte, IN | Home health agency |
| La Porte Hospital | La porte, IN | Hospital |
| Franciscan St Anthony Health - Michigan City | Michigan city, IN | Hospital |
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| Northwest Health - Porter | Valparaiso, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
University of Manchester scientists investigating a possible treatment for fetal growth restriction, a condition in which babies grow poorly in the womb, have urged further caution on the use of Viagra.
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the Sarah Cannon Research Institute in Nashville, Tennessee has opened enrollment in a Phase I clinical study with MORAb-066 in patients with advanced or metastatic breast, pancreatic, colorectal or non-small cell lung cancer (adenocarcinoma) malignancies.
Researchers from the South Australian Health and Medical Research Institute and the University of Adelaide have found a way to provide mothers and young children in Cambodia with better nutrition through an unlikely source - fish sauce.
As Asia emerges as a major engine of global economic growth, the pharmaceutical and biotechnology industries in the region are expected to experience intensified competition. According to the Economist Intelligence Unit, regional pharmaceutical sales are expected to hit USD386bn, reflecting an annual average growth rate of more than 13%.
› Verified 1 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
University of Manchester scientists investigating a possible treatment for fetal growth restriction, a condition in which babies grow poorly in the womb, have urged further caution on the use of Viagra.
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the Sarah Cannon Research Institute in Nashville, Tennessee has opened enrollment in a Phase I clinical study with MORAb-066 in patients with advanced or metastatic breast, pancreatic, colorectal or non-small cell lung cancer (adenocarcinoma) malignancies.
Researchers from the South Australian Health and Medical Research Institute and the University of Adelaide have found a way to provide mothers and young children in Cambodia with better nutrition through an unlikely source - fish sauce.
As Asia emerges as a major engine of global economic growth, the pharmaceutical and biotechnology industries in the region are expected to experience intensified competition. According to the Economist Intelligence Unit, regional pharmaceutical sales are expected to hit USD386bn, reflecting an annual average growth rate of more than 13%.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Ann Alderink, DO 710 N Niles Ave, South Bend, IN 46617-1924 Ph: (574) 647-1610 | Jennifer Ann Alderink, DO 900 I St, La Porte, IN 46350-5533 Ph: (219) 324-1700 |
News Archive
University of Manchester scientists investigating a possible treatment for fetal growth restriction, a condition in which babies grow poorly in the womb, have urged further caution on the use of Viagra.
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the Sarah Cannon Research Institute in Nashville, Tennessee has opened enrollment in a Phase I clinical study with MORAb-066 in patients with advanced or metastatic breast, pancreatic, colorectal or non-small cell lung cancer (adenocarcinoma) malignancies.
Researchers from the South Australian Health and Medical Research Institute and the University of Adelaide have found a way to provide mothers and young children in Cambodia with better nutrition through an unlikely source - fish sauce.
As Asia emerges as a major engine of global economic growth, the pharmaceutical and biotechnology industries in the region are expected to experience intensified competition. According to the Economist Intelligence Unit, regional pharmaceutical sales are expected to hit USD386bn, reflecting an annual average growth rate of more than 13%.
› Verified 1 days ago
James A Serwatka, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Teagarden, Community Health Center, La Porte, IN 46350 Phone: 219-326-0043 Fax: 219-326-8909 | |
Dr. Freeman L. Farrow, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 I St, La Porte, IN 46350 Phone: 219-324-1700 Fax: 574-324-1602 | |
John E Rogers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 Legacy Plz W, La Porte, IN 46350 Phone: 219-575-6240 Fax: 219-369-4233 | |
Caroline E Bjonback, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Legacy Plz W, La Porte, IN 46350 Phone: 219-326-1775 Fax: 219-326-1951 | |
Dr. Deborah Michelle Pavey, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 900 I St, La Porte, IN 46350 Phone: 219-324-1700 Fax: 219-324-1602 | |
Dr. Victor H Benavides Martinez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 I St Fl 2, La Porte, IN 46350 Phone: 219-324-1938 Fax: 219-324-1602 |